Previous Page  10 / 14 Next Page
Information
Show Menu
Previous Page 10 / 14 Next Page
Page Background

Page 35

Notes:

conferenceseries

.com

Volume 4, Issue 2 (Suppl)

J Pigment Disord

ISSN: 2376-0427 JPD, an open access journal

World Dermatology Congress 2017

September 25-26, 2017

September 25-26, 2017 Dubai, UAE

17

th

World Dermatology Congress

Double prevention of skin cancer: Primary and secondary forces united against actinic keratosis

Zainab Al-Nasser

National University of Ireland, Galway, Ireland

F

ortunately, skin is the only organ where even precancerous lesions can be visualized and treated to prevent the full growth

of cancer. Actinic keratosis (AK) is a scaly papule or plaque that results from sun exposure when the skin is not protected

from the sun; it is pre-cancerous and can transform into cancer if not treated. Topical Dicolfenac is a NSAID that targets the

same pathway involved in AK; it is a category based treatment of AK supported by many published researches and articles.

Theoretically; it sounds like an easy treatment option to patients who come in complaining of a rash and leave the clinic diagnosed

with precancerous lesions noticed by their dermatologist, however; the motivation can be weaned off as soon as they leave the

room. Patient compliance is an integral part of the process. Slathering on a gel about 2 to 3 times a day can be difficult to many

patients and recurrence is possible with AK, therefore primary and secondary preventions combined are needed and that makes

it even more of a challenge, as a result when a geriatric patient has to take his or her other medications plus slathering Diclofenac

and sunscreen in the morning will most likely end up with them walking out of their door with bare skin that is unprotected and

at an increased risk of developing cancer and that has been concluded in clinic by many patients. Pharmaceutical companies are

invited to work on the idea of combining Diclofenac and UVA/UVB blocking ingredients in one product, making it a lot easier

for patients with multiple AK lesions to adhere to the treatment and increasing patient compliance. For the demanding ones; a

different formula can be used such as spray to make it even easier and more fun to apply.

Biography

Zainab Al-Nasser is currently pursuing her Medical Studies from the National University of Ireland, Galway.

zainab_alnaser@yahoo.ca

Zainab Al-Nasser, J Pigment Disord 2017, 4:2 (Suppl)

DOI: 10.4172/2376-0427-C1-002